[go: up one dir, main page]

CN105136966A - Quality detection method for Liangfu pill-like preparations - Google Patents

Quality detection method for Liangfu pill-like preparations Download PDF

Info

Publication number
CN105136966A
CN105136966A CN201510367381.1A CN201510367381A CN105136966A CN 105136966 A CN105136966 A CN 105136966A CN 201510367381 A CN201510367381 A CN 201510367381A CN 105136966 A CN105136966 A CN 105136966A
Authority
CN
China
Prior art keywords
liangfu
thin
detection method
quality detection
pill
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201510367381.1A
Other languages
Chinese (zh)
Other versions
CN105136966B (en
Inventor
卢君蓉
李文兵
王世宇
傅超美
季宁平
严鑫
傅舒
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chengdu University of Traditional Chinese Medicine
Original Assignee
Chengdu University of Traditional Chinese Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chengdu University of Traditional Chinese Medicine filed Critical Chengdu University of Traditional Chinese Medicine
Priority to CN201510367381.1A priority Critical patent/CN105136966B/en
Publication of CN105136966A publication Critical patent/CN105136966A/en
Application granted granted Critical
Publication of CN105136966B publication Critical patent/CN105136966B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a quality detection method for Liangfu (of which the main compositions are rhizoma alpiniae officinarum and rhizoma cyperi) pill-like preparations. The method is a thin-layer chromatography method, and detection is performed by taking alpha-cyperone, cyperotundone, nootkatone, galangin and kaempferol as index components. The expansion conditions of the thin-layer chromatography comprise petroleum ether and ethyl acetate with the volume ratio of 5:1, and the thin-layer plate is silica gel GF254 plate. The quality detection method is capable of simultaneously detecting five index components in the Liangfu pill-like preparations, the environment adaptability is high, the method is simple, separation of the index components is good, and effective guarantee is provided for comprehensive detection on the quality of the Liangfu pill-like preparations.

Description

一种良附丸类制剂的质量检测方法A kind of quality detection method of Liangfu pill preparation

技术领域technical field

本发明涉及药物质量控制方法技术领域,具体涉及一种良附丸类制剂的质量检测方法。The invention relates to the technical field of drug quality control methods, in particular to a quality detection method for Liangfu pill preparations.

背景技术Background technique

良附丸首载于清·谢元庆之《良方集腋》,是由高良姜、醋香附两味中药等份、粉碎、混合而制成的水泛丸,为治疗寒凝气滞胃脘疼痛的代表制剂,在中医临床应用已有近千年的历史。作为典型的中药复方传统制剂,良附丸药味组成固定,制备工艺简单,临床疗效显著,极具开发的潜力。Liangfu pills were first recorded in "Liangfang Jixiong" written by Xie Yuanqing in the Qing Dynasty. The representative preparation of TCM has a history of nearly a thousand years in clinical application of traditional Chinese medicine. As a typical traditional Chinese medicine compound preparation, Liangfu Pills has a fixed medicinal composition, simple preparation process, remarkable clinical curative effect and great potential for development.

作为一种中药复方制剂,良附丸具有多成分、多靶点、多层次、整体作用的特点,但中国药典2010年版一部中仅以α-香附酮作为良附丸指标成分,难以准确、全面地反映制剂的质量,更不能代表其功能与主治。As a compound preparation of traditional Chinese medicine, Liangfu pill has the characteristics of multi-component, multi-target, multi-level, and overall effect. However, in the first part of the Chinese Pharmacopoeia 2010 edition, only α-cyperone is used as the index component of Liangfu pill, so it is difficult to accurately , comprehensively reflect the quality of the preparation, let alone its function and indications.

因此,目前需要一种能全面反映良附丸类制剂质量的检测方法。Therefore, there is a need for a detection method that can fully reflect the quality of Liangfu pill preparations.

发明内容Contents of the invention

发明人通过研究发现,α-香附酮、香附烯酮、圆柚酮可以作为醋香附的指标成分,高良姜素和山柰素可以作为高良姜的指标成分。因此,本发明以α-香附酮、香附烯酮、圆柚酮、高良姜素、山柰素5个成分作为质量检测的指标成分。The inventors have found through research that α-cyperone, cyperenone, and narone can be used as index components of cyperone, and galangin and kaempferol can be used as index components of galangal. Therefore, the present invention uses α-cyperone, cyperenone, citron, galangin, and kaempferin as index components for quality detection.

因此,为解决上述问题,本发明提供了一种良附丸类制剂的质量检测方法,本方法是薄层色谱方法,它包括以下步骤:Therefore, in order to solve the above problems, the invention provides a kind of quality detection method of Liangfu pill preparation, and this method is thin-layer chromatography method, and it comprises the following steps:

(1)取α-香附酮、香附烯酮、圆柚酮、高良姜素、山柰素对照品,混合,加甲醇配制成对照品溶液;(1) get α-cyperone, cyperenone, citron, galangin, kaempferin reference substance, mix, add methanol and be mixed with reference substance solution;

(2)将对照品溶液在薄层板上点样,展开剂展开后,取出检视即可,得到α-香附酮、香附烯酮、圆柚酮、高良姜素、山柰素的Rf值;所述展开剂为体积比5∶1的石油醚-乙酸乙酯;薄层板为硅胶GF254板;(2) Spot the reference substance solution on the thin-layer plate, after the developer is developed, take it out for inspection, and obtain the Rf of α-cyperone, cyperenone, citron, galangin and kaempferol Value; The developer is petroleum ether-ethyl acetate with a volume ratio of 5:1; the thin-layer plate is a silica gel GF 254 plate;

(3)取良附丸类制剂或其粉末,加入甲醇提取,过滤;(3) Take Liangfu pill preparation or its powder, add methanol to extract, and filter;

(4)将步骤(3)所得滤液挥干,残渣加甲醇溶解,作为供试品溶液;(4) evaporate the filtrate gained in step (3) to dryness, add methanol to dissolve the residue, as need testing solution;

(5)按照步骤(2)的薄层色谱方法进行检测,将薄层板上各斑点的Rf值与α-香附酮、香附烯酮、圆柚酮、高良姜素、山柰素对照品的Rf值比对,可知良附丸类制剂的质量情况。(5) detect according to the thin-layer chromatography method of step (2), the Rf value of each spot on the thin-layer plate is compared with α-cyperone, cyperenone, citron, galangin, kaempferol By comparing the Rf value of the product, we can know the quality of Liangfu pill preparations.

进一步优选地,在步骤(2)中,展开的温度为4-30℃。Further preferably, in step (2), the unfolding temperature is 4-30°C.

进一步优选地,在步骤(2)中,展开的湿度为32%-88%。Further preferably, in step (2), the unfolding humidity is 32%-88%.

进一步优选地,在步骤(2)中,所述点样量为2-10μL,优选为4μL。Further preferably, in step (2), the applied sample volume is 2-10 μL, preferably 4 μL.

进一步优选地,在步骤(2)中,所述检视方法为:将薄层板置紫外光灯254nm下检视;或,向薄层板喷硫酸乙醇溶液显色,加热至斑点颜色明显,置紫外灯365nm下检视。Further preferably, in step (2), the inspection method is: inspect the thin-layer board under a 254nm ultraviolet lamp; or, spray sulfuric acid ethanol solution on the thin-layer board to develop color, heat until the spot color is obvious, and put it under ultraviolet light View under lamp 365nm.

进一步优选地,所述硫酸乙醇溶液的浓度为10%。Further preferably, the concentration of the sulfuric acid ethanol solution is 10%.

进一步优选地,所述对照品溶液的浓度为1mg/mL。Further preferably, the concentration of the reference substance solution is 1 mg/mL.

进一步优选地,所述步骤(3)的提取是超声提取。Further preferably, the extraction in step (3) is ultrasonic extraction.

进一步优选地,所述超声提取的时间为30min。Further preferably, the ultrasonic extraction time is 30 minutes.

进一步优选地,在步骤(3)中,所述甲醇与良附丸类制剂或其粉末的体积重量比为25∶1mL/g;在步骤(4)中,所述甲醇与良附丸类制剂或其粉末的体积重量比为1∶1mL/g。Further preferably, in step (3), the volume-to-weight ratio of the methanol and Liangfu pill preparation or its powder is 25:1mL/g; in step (4), the methanol and Liangfu pill preparation The volume-to-weight ratio of its powder is 1:1 mL/g.

进一步优选地,所述良附丸类制剂包括良附丸、良附滴丸或良附软胶囊。Further preferably, the Liangfu pill preparations include Liangfu pills, Liangfu dropping pills or Liangfu soft capsules.

本发明的质量检测方法,可以同时检测出良附丸类制剂中的5种指标性成分(α-香附酮、香附烯酮、圆柚酮、高良姜素和山柰素),远大于中国药典2010年版一部中仅以α-香附酮作为良附丸指标成分的检测方法。同时,本发明方法简便,环境适应性高,各指标性成分分离良好,为全面检测良附丸类制剂的质量提供了有效保障。The quality detection method of the present invention can simultaneously detect 5 kinds of index components (α-cyperone, cyperenone, citron, galangin and kaempferol) in Liangfu pill preparations, which are far greater than In the Chinese Pharmacopoeia 2010 edition, only α-cyperone is used as the detection method of the indicator component of Liangfu pills. Simultaneously, the method of the invention is simple and convenient, has high environmental adaptability and good separation of each index component, and provides an effective guarantee for comprehensively testing the quality of Liangfu pill preparations.

显然,根据本发明的上述内容,按照本领域的普通技术知识和惯用手段,在不脱离本发明上述基本技术思想前提下,还可以做出其它多种形式的修改、替换或变更。Apparently, according to the above content of the present invention, according to common technical knowledge and conventional means in this field, without departing from the above basic technical idea of the present invention, other various forms of modification, replacement or change can also be made.

以下通过实施例形式的具体实施方式,对本发明的上述内容再作进一步的详细说明。但不应将此理解为本发明上述主题的范围仅限于以下凡基于本发明上述内容所实现的技术均属于本发明的范围。The above-mentioned content of the present invention will be further described in detail below through specific implementation in the form of examples. However, this should not be construed as limiting the scope of the above subject matter of the present invention to the following All technologies realized based on the above contents of the present invention belong to the scope of the present invention.

附图说明Description of drawings

在下列附图的对照品薄层色谱图中,从上到下的斑点依次为α-香附酮、香附烯酮、圆柚酮、高良姜素、山柰素。In the thin-layer chromatogram of the reference substance in the accompanying drawings, the spots from top to bottom are α-cyperone, cyperenone, citron, galangin, and kaempferol in turn.

图1为实施例1中的本发明方法在紫外光灯254nm下的薄层色谱图:1为对照品,2-5为良附丸样品。Fig. 1 is the thin-layer chromatogram of the inventive method in embodiment 1 under ultraviolet lamp 254nm: 1 is reference substance, and 2-5 is Liangfu pill sample.

图2为实施例1中的本发明方法在紫外光灯365nm下的薄层色谱图:1为对照品,2-5为良附丸样品。Fig. 2 is the thin-layer chromatogram of the inventive method in embodiment 1 under the ultraviolet lamp 365nm: 1 is reference substance, and 2-5 is Liangfu pill sample.

图3为实施例1中的对比例1方法在紫外光灯254nm下的薄层色谱图:1为对照品,2-4为良附丸样品。Fig. 3 is the thin-layer chromatogram of comparative example 1 method in the embodiment 1 under the ultraviolet lamp 254nm: 1 is the reference substance, 2-4 is the Liangfu pill sample.

图4为实施例1中的对比例1方法在紫外光灯365nm下的薄层色谱图:1为对照品,2-4为良附丸样品。Fig. 4 is the thin-layer chromatogram of comparative example 1 method in embodiment 1 under the ultraviolet lamp 365nm: 1 is reference substance, 2-4 is Liangfu pill sample.

图5为实施例1中的对比例2方法在紫外光灯254nm下的薄层色谱图:1为对照品,2-4为良附丸样品。Fig. 5 is the thin-layer chromatogram of the comparative example 2 method in the embodiment 1 under the ultraviolet lamp 254nm: 1 is the reference substance, 2-4 is the Liangfu pill sample.

图6为实施例1中的对比例2方法在紫外光灯365nm下的薄层色谱图:1为对照品,2-4为良附丸样品。Fig. 6 is the thin-layer chromatogram of the comparative example 2 method in the embodiment 1 under the ultraviolet lamp 365nm: 1 is the reference substance, 2-4 is the Liangfu pill sample.

图7为实施例1中的对比例2方法在紫外光灯254nm下的薄层色谱图:1为对照品,2-4为良附丸样品。Fig. 7 is the thin-layer chromatogram of the comparative example 2 method in the embodiment 1 under the ultraviolet lamp 254nm: 1 is the reference substance, 2-4 is the Liangfu pill sample.

图8为实施例1中的对比例2方法在紫外光灯365nm下的薄层色谱图:1为对照品,2-4为良附丸样品。Fig. 8 is the thin-layer chromatogram of the comparative example 2 method in the embodiment 1 under the ultraviolet lamp 365nm: 1 is the reference substance, 2-4 is the Liangfu pill sample.

图9为实施例2中的提取方法考察试验在紫外光灯254nm下的薄层色谱图:1为对照品,2为超声提取法,3为回流提取法。Fig. 9 is the thin-layer chromatogram of the extraction method investigation test in Example 2 under the ultraviolet lamp 254nm: 1 is the reference substance, 2 is the ultrasonic extraction method, and 3 is the reflux extraction method.

图10为实施例2中的提取方法考察试验在紫外光灯365nm下的薄层色谱图:1为对照品,2为超声提取法,3为回流提取法。Fig. 10 is the thin-layer chromatogram of the extraction method investigation test in Example 2 under the ultraviolet lamp 365nm: 1 is the reference substance, 2 is the ultrasonic extraction method, and 3 is the reflux extraction method.

图11为实施例3中的点样量考察试验在紫外光灯254nm下的薄层色谱图:1-6的点样量依次为1、2、4、6、8、10μL。Fig. 11 is the thin-layer chromatogram of the sample volume investigation test in Example 3 under the ultraviolet lamp 254nm: the sample volumes of 1-6 are 1, 2, 4, 6, 8, and 10 μL in sequence.

图12为实施例3中的点样量考察试验在紫外光灯365nm下的薄层色谱图:1-6的点样量依次为1、2、4、6、8、10μL。Fig. 12 is the thin-layer chromatogram of the sample volume investigation test in Example 3 under the ultraviolet lamp 365nm: the sample volumes of 1-6 are 1, 2, 4, 6, 8, and 10 μL in sequence.

图13-16实施例4中薄层板考察试验在紫外光灯365nm下的薄层色谱图:图9-12的薄层板依次为青岛海洋、青岛海浪、青岛裕民源、天津思利达的薄层板,1为对照品,2-5为良附丸样品。Figure 13-16 The thin layer chromatograms of the TLC investigation test in Example 4 under the ultraviolet lamp 365nm: the TLC plates in Figure 9-12 are Qingdao Haiyang, Qingdao Hailang, Qingdao Yuminyuan, Tianjin Silida 1 is the reference substance, and 2-5 are samples of Liangfu pills.

图17和18分别实施例4展开温度考察试验在紫外光灯365nm下的薄层色谱图:图13为4℃下,图14为30℃下,1为对照品,2-5为良附丸样品。Figures 17 and 18 are respectively the thin-layer chromatograms of the development temperature investigation test in Example 4 under the ultraviolet lamp at 365nm: Figure 13 is at 4°C, Figure 14 is at 30°C, 1 is the reference substance, and 2-5 are Liangfu pills sample.

图19为实施例4下各制剂在紫外光灯254nm下的薄层色谱图:1为对照品,2为高良姜对照药材,3为香附对照药材,4-9为良附丸样品,10-12为良附滴丸,13-15为良附软胶囊。Fig. 19 is the thin-layer chromatogram of each preparation under the embodiment 4 under the ultraviolet lamp 254nm: 1 is the reference substance, 2 is the reference medicinal material of galanga, 3 is the reference medicinal material of Cyperus cyperi, 4-9 is the sample of Liangfu pills, 10 -12 is Liangfu dropping pill, and 13-15 is Liangfu soft capsule.

图20为实施例4下各制剂在紫外光灯365nm下的薄层色谱图:1为对照品,2为高良姜对照药材,3为香附对照药材,4-9为良附丸样品,10-12为良附滴丸,13-15为良附软胶囊。Fig. 20 is the thin-layer chromatogram of each preparation under the ultraviolet lamp 365nm under embodiment 4: 1 is reference substance, 2 is galanga reference medicinal material, 3 is Cyperus cyperi reference medicinal material, 4-9 is Liangfu pill sample, 10 -12 is Liangfu dropping pill, and 13-15 is Liangfu soft capsule.

具体实施方式Detailed ways

本发明具体实施方式中的原料、仪器与试剂的来源如下:The source of raw material, instrument and reagent in the specific embodiment of the present invention is as follows:

KQ5200DB型数控超声波清洗器(昆山市超声仪器有限公司);硅胶G薄层板(青岛海洋化工厂,自制硅胶G板)。KQ5200DB CNC ultrasonic cleaner (Kunshan Ultrasonic Instrument Co., Ltd.); silica gel G thin-layer board (Qingdao Ocean Chemical Factory, self-made silica gel G board).

良附丸(北京同仁堂制药有限公司)、良附软胶囊(天津太平洋制药有限公司)、良附滴丸(贵州黄果树立爽药业有限公司);高良姜素(中国药品生物制品检定所,111699-200501)、山柰素(成都曼思特生物科技有限公司,must-12020812),圆柚酮(美国Sigma公司、10112423)、α-香附酮(江西本草天工科技有限责任公司,1443-080529)、香附烯酮(自制)、香附对照药材(中国药品生物制品检定所,120918-200809)、高良姜对照药材(中国药品生物制品检定所,1263-0301)。Liangfu Pills (Beijing Tongrentang Pharmaceutical Co., Ltd.), Liangfu Soft Capsules (Tianjin Pacific Pharmaceutical Co., Ltd.), Liangfu Dropping Pills (Guizhou Huangguo Lishuang Pharmaceutical Co., Ltd.); Galangin (China Institute for the Control of Pharmaceutical and Biological Products, 111699 -200501), kaempferone (Chengdu Mansite Biotechnology Co., Ltd., must-12020812), narone (US Sigma Company, 10112423), α-cyperone (Jiangxi Bencao Tiangong Technology Co., Ltd., 1443- 080529), cyperenone (self-made), Cyperus reference medicinal materials (National Institute for the Control of Pharmaceutical and Biological Products, 120918-200809), galangal reference medicinal materials (National Institute for the Control of Pharmaceutical and Biological Products, 1263-0301).

石油醚(60-90℃)、乙酸乙酯、环己烷、丙酮、甲醇均为分析纯,由成都科龙化工试剂厂提供。Petroleum ether (60-90°C), ethyl acetate, cyclohexane, acetone, and methanol were all analytically pure, provided by Chengdu Kelong Chemical Reagent Factory.

实施例1Example 1

1、对照品溶液的制备:取高良姜素、山柰素、圆柚酮、α-香附酮、香附烯酮对照品适量,加甲醇制成每1mL含1mg的溶液,作为对照品溶液。1. Preparation of reference substance solution: Take an appropriate amount of reference substance of galangin, kaempferone, citronone, α-cyperone, and cyperenone, and add methanol to make a solution containing 1 mg per 1 mL, as the reference substance solution .

2、供试品溶液制备:取良附丸粉末1g,加甲醇25mL,超声处理30min,滤过,将滤液挥干,残渣加甲醇1mL使溶解,作为供试品溶液。2. Preparation of the test solution: Take 1 g of Liangfu pill powder, add 25 mL of methanol, sonicate for 30 minutes, filter, evaporate the filtrate to dryness, add 1 mL of methanol to dissolve the residue, and use it as the test solution.

3、薄层色谱条件:3. TLC conditions:

展开剂:石油醚(60-90℃)-乙酸乙酯(5∶1);Developing agent: petroleum ether (60-90°C)-ethyl acetate (5:1);

薄层板:硅胶GF254板;Thin layer board: silica gel GF 254 board;

点样量:供试品溶液、对照品溶液各4μL;Sample volume: 4 μL each for the test solution and the reference solution;

温度为22℃,相对湿度为58%。The temperature was 22°C and the relative humidity was 58%.

4、检视:置紫外光灯254nm下检视,结果如图1所示,各指标成分斑点明显,分离良好;再喷以10%硫酸乙醇显色,105℃加热至斑点颜色明显,置紫外灯365nm下检视,结果如图2所示,各指标成分斑点明显,分离良好。4. Inspection: inspect under the ultraviolet lamp at 254nm, the results are shown in Figure 1, the spots of each index component are obvious and well separated; then spray with 10% sulfuric acid ethanol for color development, heat at 105°C until the spot color is obvious, and place the ultraviolet lamp at 365nm Under the inspection, the results are shown in Figure 2. The spots of each index component are obvious and well separated.

对比例1Comparative example 1

1、对照品溶液的制备:取高良姜素、山柰素、圆柚酮、α-香附酮、香附烯酮对照品适量,加甲醇制成每1mL含1mg的溶液,作为对照品溶液。1. Preparation of the reference substance solution: take an appropriate amount of reference substances of galangin, kaempferone, citronone, α-cyperone, and cyperenone, and add methanol to make a solution containing 1 mg per 1 mL as the reference substance solution .

2、供试品溶液制备:取良附丸粉末1g,加甲醇25mL,超声处理30min,滤过,滤液,挥干,残渣加甲醇1mL使溶解,作为供试品溶液。2. Preparation of the test solution: Take 1 g of Liangfu pill powder, add 25 mL of methanol, ultrasonically treat for 30 minutes, filter, evaporate the filtrate to dryness, add 1 mL of methanol to dissolve the residue, and use it as the test solution.

3、薄层色谱条件:3. TLC conditions:

展开剂:环己烷-丙酮(3∶1);Developing agent: cyclohexane-acetone (3:1);

薄层板:硅胶GF254板;Thin layer board: silica gel GF 254 board;

点样量:供试品溶液、对照品溶液各4μl;Sample volume: 4 μl each of the test solution and the reference solution;

温度为22℃,相对湿度为58%。The temperature was 22°C and the relative humidity was 58%.

4、检视:置紫外光灯(254nm)下检视,结果如图3所示,各指标成分斑点不明显,分离较差;再喷以10%硫酸乙醇显色,105℃加热至斑点颜色明显,置紫外灯(365nm)下检视,结果如图4所示,各指标成分,斑点不明显,分离较差。4. Inspection: put it under the ultraviolet lamp (254nm) to inspect, the results are shown in Figure 3, the spots of each index component are not obvious, and the separation is poor; then spray with 10% sulfuric acid ethanol for color development, and heat at 105°C until the spots are clearly colored. Put under the ultraviolet lamp (365nm) to examine, the result is shown in Figure 4, each index component, the spot is not obvious, and separation is poor.

对比例2Comparative example 2

按照实施例1的方法,区别在于展开剂为石油醚-乙酸乙酯=3∶1,其他条件不变,结果如图5和图6所示。According to the method of Example 1, the difference is that the developer is petroleum ether-ethyl acetate=3:1, and other conditions remain unchanged. The results are shown in Figures 5 and 6.

可以看出,在该条件下,α-香附酮、香附烯酮、圆柚酮未能成功分离开。It can be seen that under this condition, α-cyperone, cyperenone, and narone were not successfully separated.

对比例3Comparative example 3

按照实施例1的方法,区别在于展开剂为石油醚-乙酸乙酯=7∶1,其他条件不变,结果如图7和图8所示。According to the method of Example 1, the difference is that the developer is petroleum ether-ethyl acetate=7:1, and other conditions remain unchanged, the results are shown in Figure 7 and Figure 8.

可以看出,在该条件下,高良姜素、山柰素展距太小,未能完全分开。It can be seen that under this condition, the span of galangin and kaempferol is too small to be completely separated.

通过对比可知,本发明的方法较之对比例的方法,待检测5个成分Rf值适中,主要显色斑点清晰且分离度较好,且灵敏度高,方法稳定,重现性好。It can be seen from the comparison that, compared with the method of the comparative example, the method of the present invention has moderate Rf values of the five components to be detected, clear main color spots and better separation, high sensitivity, stable method and good reproducibility.

实施例2提取方法考察Embodiment 2 extraction method investigation

取良附丸粉末1g,加甲醇25mL,分别考察回流提取和超声2种提取方法,提取时间为30min,滤过,滤液,挥干,残渣加甲醇1mL使溶解,作为供试品溶液,薄层色谱条件和检视方法同实施例1,结果如图9和图10所示。Take 1g of Liangfu pill powder, add 25mL of methanol, investigate the two extraction methods of reflux extraction and ultrasonic extraction respectively, the extraction time is 30min, filter, the filtrate, evaporate to dryness, add 1mL of methanol to the residue to dissolve, as the test solution, TLC Chromatographic conditions and inspection methods are the same as in Example 1, and the results are shown in Figures 9 and 10.

结果表明,两种提取方法中主要斑点均较清晰。由于超声提取法操作更为简单、方便,故本发明优选超声提取法法作为供试品制备方法。The results show that the main spots are clearer in both extraction methods. Because the operation of the ultrasonic extraction method is simpler and more convenient, the preferred ultrasonic extraction method is used as the preparation method of the test sample in the present invention.

实施例3点样量考察Example 3 point sample volume investigation

按照实施例1的方法,取同一硅胶GF254薄层板,分别考察1、2、4、6、8、10μL的点样量。结果如图11和图12所示。According to the method of Example 1, the same silica gel GF254 thin-layer plate was taken, and the sample volumes of 1, 2, 4, 6, 8, and 10 μL were investigated respectively. The results are shown in Figure 11 and Figure 12.

结果表明,供试品溶液点样量为2-10μL时斑点的清晰度和分离度都较好,其中最佳点样量为4μL。The results showed that when the spotting volume of the test solution was 2-10 μL, the clarity and separation of the spots were better, and the optimum spotting volume was 4 μL.

实施例4耐用性考察Embodiment 4 durability investigation

1、不同厂家薄层板的考察1. Inspection of thin-layer boards from different manufacturers

按照实施例1的方法,选取青岛海浪、青岛海洋、青岛裕民源、天津思利达薄层板,结果如图13-16所示。According to the method of Example 1, Qingdao Hailang, Qingdao Haiyang, Qingdao Yuminyuan, and Tianjin Sleda thin-layer panels were selected, and the results are shown in Figures 13-16.

结果表明,本发明方法对不同品牌的薄层板适应性较好,均能达到鉴别要求。The results show that the method of the present invention has good adaptability to different brands of thin-layer boards, and can meet the identification requirements.

2、不同温度的考察2. Investigation of different temperatures

按照实施例1的方法,取点样后的薄层板,在相对湿度(RH)54%的条件下,分别在4℃和30℃的温度环境下进行展开,结果如图17和18所示。According to the method of Example 1, the thin-layer plate after sampling was taken, and the relative humidity (RH) was 54%, and the temperature environment was respectively developed at 4°C and 30°C. The results are shown in Figures 17 and 18. .

结果表明,本发明方法对不同温度的适应性较好,均能达到鉴别要求。The results show that the method of the present invention has good adaptability to different temperatures and can meet the identification requirements.

3不同湿度的考察3 Investigation of different humidity

按照实施例1的方法,取点样后的薄层板,在25℃的条件下,分别在32%和88%的湿度环境下进行展开。According to the method of Example 1, the thin-layer plate after sampling was taken, and developed under the condition of 25° C. and humidity environments of 32% and 88%, respectively.

结果表明,本发明方法对不同湿度的适应性较好,均能达到鉴别要求。The results show that the method of the present invention has good adaptability to different humidity and can meet the identification requirements.

4、不同批良附丸及其制剂的考察4. Investigation of different batches of Liangfu pills and their preparations

取样品12批,按实施例1方法进行实验,结果如图19和图20所示。Twelve batches of samples were taken, and experiments were carried out according to the method of Example 1, and the results are shown in Figures 19 and 20.

结果表明,供试品色谱图中,在与对照药材和和对照品色谱相应的位置上,显相同颜色的荧光斑点。说明本发明方法稳定性高,重现性好,可以对良附丸及其各种试剂进行有效检测。The results showed that in the chromatogram of the test product, there were fluorescent spots of the same color at the positions corresponding to the chromatograms of the reference medicinal material and the reference product. It shows that the method of the present invention has high stability and good reproducibility, and can effectively detect Liangfu pills and various reagents thereof.

综上所述,本发明的质量检测方法,可以同时检测出良附丸类制剂中的5种指标性成分(α-香附酮、香附烯酮、圆柚酮、高良姜素和山柰素),远大于中国药典2010年版一部中仅以α-香附酮作为良附丸指标成分的检测方法。同时,本发明方法简便,环境适应性高,各指标性成分分离良好,为全面检测良附丸类制剂的质量提供了有效保障。In summary, the quality detection method of the present invention can simultaneously detect 5 kinds of index components (α-cyperone, cyperenone, citron, galangin and kaempferone) in Liangfu pill preparations element), which is far greater than the detection method in the Chinese Pharmacopoeia 2010 edition, which only uses α-cyperone as the index component of Liangfu pills. Simultaneously, the method of the invention is simple and convenient, has high environmental adaptability and good separation of each index component, and provides an effective guarantee for comprehensively testing the quality of Liangfu pill preparations.

Claims (10)

1.一种良附丸类制剂的质量检测方法,其特征在于:所述方法是薄层色谱方法,它包括以下步骤:1. a quality detection method of Liangfu pill preparations, characterized in that: the method is a thin-layer chromatography method, and it may further comprise the steps: (1)取α-香附酮、香附烯酮、圆柚酮、高良姜素、山柰素对照品,混合,加甲醇配制成对照品溶液;(1) get α-cyperone, cyperenone, citron, galangin, kaempferin reference substance, mix, add methanol and be mixed with reference substance solution; (2)将对照品溶液在薄层板上点样,展开剂展开后,取出检视即可,得到α-香附酮、香附烯酮、圆柚酮、高良姜素、山柰素的Rf值;所述展开剂为体积比5:1的石油醚-乙酸乙酯;薄层板为硅胶GF254板;(2) Spot the reference substance solution on the thin-layer plate, after the developer is developed, take it out for inspection, and obtain the Rf of α-cyperone, cyperenone, citron, galangin and kaempferol Value; The developer is petroleum ether-ethyl acetate with a volume ratio of 5:1; the thin-layer plate is a silica gel GF 254 plate; (3)取良附丸类制剂或其粉末,加入甲醇提取,过滤;(3) Take Liangfu pill preparation or its powder, add methanol to extract, and filter; (4)将步骤(3)所得滤液挥干,残渣加甲醇溶解,作为供试品溶液;(4) evaporate the filtrate gained in step (3) to dryness, add methanol to dissolve the residue, as need testing solution; (5)按照步骤(2)的薄层色谱方法进行检测,将薄层板上各斑点的Rf值与α-香附酮、香附烯酮、圆柚酮、高良姜素、山柰素对照品的Rf值比对,可知良附丸类制剂的质量情况。(5) detect according to the thin-layer chromatography method of step (2), the Rf value of each spot on the thin-layer plate is compared with α-cyperone, cyperenone, citron, galangin, kaempferol By comparing the Rf value of the product, we can know the quality of Liangfu pill preparations. 2.根据权利要求1所述的质量检测方法,其特征在于:在步骤(2)中,展开的温度为4-30℃。2. The quality detection method according to claim 1, characterized in that: in step (2), the unfolding temperature is 4-30°C. 3.根据权利要求1所述的质量检测方法,其特征在于:在步骤(2)中,展开的湿度为32%-88%。3. The quality detection method according to claim 1, characterized in that: in the step (2), the unfolded humidity is 32%-88%. 4.根据权利要求1所述的质量检测方法,其特征在于:在步骤(2)中,所述点样量为2-10μL,优选为4μL。4 . The quality detection method according to claim 1 , characterized in that: in step (2), the applied sample volume is 2-10 μL, preferably 4 μL. 5.根据权利要求1所述的质量检测方法,其特征在于:在步骤(2)中,所述检视方法为:将薄层板置紫外光灯254nm下检视;5. The quality detection method according to claim 1, characterized in that: in step (2), the inspection method is: inspecting the thin-layer plate under a 254nm ultraviolet lamp; 或,向薄层板喷硫酸乙醇溶液显色,加热至斑点颜色明显,置紫外灯365nm下检视。Or, spray sulfuric acid ethanol solution on the thin-layer plate to develop color, heat until the spot color is obvious, and inspect it under a 365nm ultraviolet lamp. 6.根据权利要求5所述的质量检测方法,其特征在于:所述硫酸乙醇溶液的浓度为10%。6. The quality detection method according to claim 5, characterized in that: the concentration of the sulfuric acid ethanol solution is 10%. 7.根据权利要求1所述的质量检测方法,其特征在于:所述对照品溶液的浓度为1mg/mL。7. The quality detection method according to claim 1, characterized in that: the concentration of the reference substance solution is 1 mg/mL. 8.根据权利要求1所述的质量检测方法,其特征在于:所述步骤(3)的提取是超声提取。8. The quality detection method according to claim 1, characterized in that: the extraction in the step (3) is ultrasonic extraction. 9.根据权利要求1-8任一一项所述的质量检测方法,其特征在于:在步骤(3)中,所述甲醇与良附丸类制剂或其粉末的体积重量比为25:1mL/g;在步骤(4)中,所述甲醇与良附丸类制剂或其粉末的体积重量比为1:1mL/g。9. according to the quality detection method described in any one of claim 1-8, it is characterized in that: in step (3), the volume-to-weight ratio of described methanol and Liangfu pill preparation or its powder is 25:1mL /g; In step (4), the volume-to-weight ratio of the methanol and the Liangfu pill preparation or its powder is 1:1mL/g. 10.根据权利要求1所述的质量检测方法,其特征在于:所述良附丸类制剂包括良附丸、良附滴丸或良附软胶囊。10. The quality detection method according to claim 1, characterized in that: the Liangfu pill preparations include Liangfu pills, Liangfu dripping pills or Liangfu soft capsules.
CN201510367381.1A 2015-06-29 2015-06-29 A kind of quality determining method of Liang Fu Wan class preparation Expired - Fee Related CN105136966B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510367381.1A CN105136966B (en) 2015-06-29 2015-06-29 A kind of quality determining method of Liang Fu Wan class preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510367381.1A CN105136966B (en) 2015-06-29 2015-06-29 A kind of quality determining method of Liang Fu Wan class preparation

Publications (2)

Publication Number Publication Date
CN105136966A true CN105136966A (en) 2015-12-09
CN105136966B CN105136966B (en) 2016-08-17

Family

ID=54722391

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510367381.1A Expired - Fee Related CN105136966B (en) 2015-06-29 2015-06-29 A kind of quality determining method of Liang Fu Wan class preparation

Country Status (1)

Country Link
CN (1) CN105136966B (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105628853A (en) * 2015-12-22 2016-06-01 新疆奇康哈博维药股份有限公司 Quality detection method for medicinal herb herba cymbopogonis
CN107389818A (en) * 2017-07-24 2017-11-24 朱建友 A kind of medicine for treating Parkinson and preparation method thereof and detection method and purposes
CN109596765A (en) * 2018-12-25 2019-04-09 贵州黄果树立爽药业有限公司 The detection method of liangfuwan
CN110940756A (en) * 2019-12-21 2020-03-31 陕西中医药大学 Method for evaluating quality of rhizoma acori graminei by using one-test-multiple evaluation method

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1363313A (en) * 2001-01-10 2002-08-14 杨孟君 Nano medicine 'Liangfu' and its preparing process
US20040005343A1 (en) * 2002-07-03 2004-01-08 Zhu Betty C. R. Dihydronootkatone and tetrahydronootkatone as repellents to arthropods
CN1660380A (en) * 2005-01-14 2005-08-31 贵州黄果树立爽药业有限公司 Preparation method and quality control method of Liangfu dropping pills
CN101824020A (en) * 2010-05-26 2010-09-08 南京泽朗农业发展有限公司 Method for extracting galangin from galangal
EP2649991A1 (en) * 2012-04-13 2013-10-16 King Saud University Extracts and isolated compounds from Euphorbia granulata Forrsk. for treatment of ulcerative colitis
CN104341379A (en) * 2013-08-02 2015-02-11 上海友思生物技术有限公司 Galangin extraction method

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1363313A (en) * 2001-01-10 2002-08-14 杨孟君 Nano medicine 'Liangfu' and its preparing process
US20040005343A1 (en) * 2002-07-03 2004-01-08 Zhu Betty C. R. Dihydronootkatone and tetrahydronootkatone as repellents to arthropods
CN1660380A (en) * 2005-01-14 2005-08-31 贵州黄果树立爽药业有限公司 Preparation method and quality control method of Liangfu dropping pills
CN101824020A (en) * 2010-05-26 2010-09-08 南京泽朗农业发展有限公司 Method for extracting galangin from galangal
EP2649991A1 (en) * 2012-04-13 2013-10-16 King Saud University Extracts and isolated compounds from Euphorbia granulata Forrsk. for treatment of ulcerative colitis
CN104341379A (en) * 2013-08-02 2015-02-11 上海友思生物技术有限公司 Galangin extraction method

Non-Patent Citations (8)

* Cited by examiner, † Cited by third party
Title
JUANA . GARBARINO 等: "THE STRUCTURE OF CORYMBOLONE, AN EUDESMANE SESQUITERPENOID KETO-ALCOHOL FROM CYPERUS CORYMBOSUS", 《JOURNAL OF NATURAL PRODUCTS》 *
MESMIN MEKEM SONWA 等: "Chemical study of the essential oil of Cyperus rotundus", 《PHYTOCHEMISTRY》 *
SEI-JOON JEONG 等: "Rotundines A-C, Three Novel Sesquiterpene Alkaloids from Cyperus rotundus", 《J. NAT. PROD.》 *
卢君蓉 等: "香附药材的质量控制方法的探讨", 《中国医院药学杂志》 *
涂瑶生 等: "高良姜配方颗粒质量控制研究", 《中国实验方剂学杂志》 *
王世宇 等: "HPLC法同时测定不同产地香附药材中香附烯酮、圆柚酮和α-香附酮", 《中成药》 *
翟志光 等: "HPLC测定良附口服液中α-香附酮的含量", 《中国中药杂志》 *
翟红莉 等: "不同产地高良姜的有效成分分析", 《热带生物学报》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105628853A (en) * 2015-12-22 2016-06-01 新疆奇康哈博维药股份有限公司 Quality detection method for medicinal herb herba cymbopogonis
CN107389818A (en) * 2017-07-24 2017-11-24 朱建友 A kind of medicine for treating Parkinson and preparation method thereof and detection method and purposes
CN109596765A (en) * 2018-12-25 2019-04-09 贵州黄果树立爽药业有限公司 The detection method of liangfuwan
CN110940756A (en) * 2019-12-21 2020-03-31 陕西中医药大学 Method for evaluating quality of rhizoma acori graminei by using one-test-multiple evaluation method
CN110940756B (en) * 2019-12-21 2021-10-01 陕西中医药大学 A method for evaluating the quality of calamus

Also Published As

Publication number Publication date
CN105136966B (en) 2016-08-17

Similar Documents

Publication Publication Date Title
CN105136966B (en) A kind of quality determining method of Liang Fu Wan class preparation
CN101581712A (en) Quick test method of biguanide compounds added in hypoglycemic medicine, health care products or food and application thereof
CN105954380A (en) Determination method for linarin in Buddleja officinalis
CN103884815A (en) Method for inspecting quality of haemorrhoids suppository
CN105628853B (en) A kind of quality determining method of cymbopogon distans medicinal material
CN104991032B (en) Differentiate to adulterate in Fructus Schisandrae Chinensis the thin layer chromatography of Fructus Schisandrae Sphenantherae
CN109459515B (en) Herba epimedii control extract (arrow leaf) and application thereof
AU2024290838A1 (en) Thin-layer chromatography identification method for rhizoma dioscoreae hypoglaucae formula granules
CN104777244A (en) Quality detection method for qi-moving Tannikaer capsule
CN116298051A (en) A TLC identification method of Phellodendron Phellodendron in Ermiao Pills
CN111122732A (en) Quality detection method for caulis mahoniae medicine
CN104698120B (en) Thin-layer chromatography identification method for rhizoma anemarrhenae in antibacterial and anti-inflammatory capsules
CN112697950B (en) Thin-layer chromatography identification method of pyrrosia lingua
CN104237230A (en) Quick melatonin detection method and operation utensil assembly thereof
CN103940943B (en) A kind of discrimination method of field pennycress medicinal material
CN105092771B (en) Thin-layer chromatography rapid identification method for Pothos chinensis
CN108267537A (en) A kind of method of Cortex Phellodendri in discriminating shangqing pill
CN102023157B (en) Quick measurement method for pyrazolone substances doped in medicaments and health-care food
CN102721782A (en) Method for detecting quality of philippine flemingia root formula granules
CN107991424B (en) The detection method of grub
CN102018755A (en) Quality detection method of furan lightyellow sophora root berberine tablet
CN113759063B (en) Thin-layer identification method for reed rhizome and preparation thereof
CN111595997B (en) Mulberry mistletoe quality control method based on double-substance component qualitative detection
Chen et al. Reusability of Bond Elut Certify columns for the extraction of drugs from plasma
CN101352558A (en) Quality control method of granular formulation for treating gastricism without aversion to cold

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160817